Ant Group’s AI Health Service AQ Upgrades PC Platform with DeepSearch for Evidence-Based Clinical Decision Support
HANGZHOU, China–(BUSINESS WIRE)–Ant Group today announced a major upgrade to the PC platform of its AI-native health assistant, AQ, introducing DeepSearch for clinicians, a new capability designed to support evidence-based clinical decision-making. The service is available free of charge to clinicians and medical students.
AQ’s PC platform provides medical professionals with two core capabilities: Health Q&A and DeepSearch. It supports medical literature search, clinical practice, and research, helping reduce clinicians’ day-to-day workload while improving access to high-quality medical information.
To ensure accuracy and reliability, AQ rigorously curates its sources based on recognized levels of evidence. The platform integrates more than 36 million high-quality Chinese and international medical publications, making its clinical decision support closely aligned with real-world practice.
DeepSearch enables clinicians to rapidly access the latest clinical guidelines across specialties. Using AI-driven synthesis and organization, it structures large volumes of research based on clinical needs, significantly reducing the time required for information retrieval and review.
Beyond literature search, DeepSearch now supports evidence-based clinical decision support. In routine practice, developing treatment strategies for complex cases often requires extensive guideline consultation and literature verification. DeepSearch helps clinicians stay current with global diagnostic and therapeutic approaches, rapidly aggregates supporting evidence, and delivers logically structured, clinically relevant recommendations—enabling clearer and more robust treatment planning.
DeepSearch also features traceable citations, evidence-level filtering, and fast alignment with authoritative clinical guidelines, further easing the clinical and research burden on healthcare professionals.
AQ, known in Chinese as Ant A-Fu, is an AI-native health service launched by Ant Group in June 2025. For everyday users, AQ focuses on addressing common health concerns and supporting healthy habit formation, particularly for routine needs that do not yet require a hospital visit.
The platform connects users with digital services from more than 5,000 hospitals nationwide and provides access to online consultations with 300,000 licensed physicians.
AQ has also partnered with more than 1,000 leading physicians across China to develop AI Doctor Agents—their digital doubles—on the platform. Trained on each physician’s clinical expertise, these agents offer free, reliable answers to users’ common health questions and collectively responded to over 27 million inquiries in 2025.
As of January 2026, the AQ app has reached 30 million monthly active users and handles more than 10 million health-related queries daily, making it China’s leading AI-native health application.
About Ant Group
Ant Group is a global digital technology provider and the operator of Alipay, a leading internet services platform in China, connecting over one billion users to more than 10,000 types of consumer services from partners. Through innovative products and solutions powered by AI, blockchain and other technologies, Ant Group supports partners across industries to thrive through digital transformation in an ecosystem for inclusive and sustainable development. For more information, visit www.antgroup.com.
Contacts
Media Inquiries
Yinan Duan
[email protected]
You May Also Like
The rise of the AI orchestrators
Breaking: CME Group Unveils Solana and XRP Options
